Esther J Beck

6PUBLICATIONS
26CO-AUTHORS
Probability theoryPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied statistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 01, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials.

|Jan 31, 2025
Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials.

Alexander D Sherry, Pavlos Msaouel, Timothy A Lin

|Jan 08, 2025
Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials.

Avital M Miller, Adina H Passy, Alexander D Sherry

|Dec 10, 2024
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study.

Troy J Kleber, Alexander D Sherry, Andrew J Arifin

|Aug 30, 2024
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses.

Alexander D Sherry, Adina H Passy, Zachary R McCaw

|Aug 05, 2024
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials.

Esther J Beck, Alexander D Sherry, Marcus A Florez

Pageof 1

Frequent Collaborators

6 joint publications

Alexander D Sherry

5 joint publications

Ramez Kouzy

5 joint publications

Timothy A Lin

5 joint publications

Avital M Miller